Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gmc-252-l-lysine (2 trials)
Diabetes Mellitus, Type 2 (Phase 1)
Trials (2 total)
Trial APIs (1 total)